RIPK3 and amyotrophic lateral sclerosis: Re et al. [147], for the first time, reported that the mechanisms underlying loss of MN degeneration in ALS were dependent on RIPK1/RIPK3/MLKL-mediated necroptosis but not on caspase-dependent pathways.